Ketamine’s rapid impact on depression linked to immune system pathways

FHS
April 15, 2024
11:18 pm

Study reveals ketamine’s potent anti-inflammatory effects on neurological disorders, showing promise for treating major depressive disorder through modulation of neuroimmune pathways.

Opinion | From Salad Roulette to Salmonella in Poultry and Peanuts

Panosian Dunavan is an infectious diseases expert. In August 2006, Ruby Trautz of Omaha, Nebraska was the first person of several to die in a

August 18, 2023

Numinus Submits MDMA Group Therapy Clinical Trial Application

The TDR Three Takeaways for Numinus Numinus Wellness Inc. has applied for a clinical trial to explore MDMA-assisted psychotherapy in a group setting, aiming to

March 22, 2024

Masking Policies Show Clear Impact on Hospital-Onset Respiratory Infections

In this exclusive MedPage Today video, Theodore Pak, MD, PhD, of Harvard Medical School in Boston, discusses the findings from a study that examined how

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.